Public Invest Research ups Daiman target price to RM7.79

KUALA LUMPUR: Public Invest Research has revised Daiman Development’s fair value from RM7.22 to RM7.79 per share, underpinned by further deep underlying value in the company after re-rating the commercial land in Plentong, Johor.

It said on Tuesday it recently had a meeting with Daiman Development’s management in Johor Bahru and came away with more positive prospects of the company after seeing the upcoming developments.

“We are convinced that the developments will spark renewed interest in the company and would also become one of the key earnings drivers for the group’s future earnings,” it said.

Public Invest Research said the upcoming joint venture development in Plentong as well as the opening of “DoubleTree by Hilton” hotel next month in Johor Bahru will see exciting recurring income coming on stream soon.

“Meanwhile, we also see further deep underlying value in the company after re-rating the commercial land in Plentong from RM70 psf to RM140 psf as we decide to benchmark against the transacted price used when they disposed the 50% stake in the 12.3-acre land to its JV partners,” it said.

Source: The Star Online

Share:

Facebook
Twitter
Pinterest
LinkedIn
You May Like

Related Posts

Public Invest Research ups Daiman target price to RM7.79

KUALA LUMPUR: Public Invest Research has revised Daiman Development’s fair value from RM7.22 to RM7.79 per share, underpinned by further deep underlying value in the company after re-rating the commercial land in Plentong, Johor. It said on Tuesday it recently

Daiman Plans 128ha Industrial Park

JOHOR BARU: Daiman Development Bhd is planning to turn a freehold 128.78ha agriculture land near Kulaijaya into a gated and guarded industrial park cum commercial outlets in its latest development. Its property management general manager Heng Song Teck said the land

Group supports cancer foundation

THE Tunku Laksamana Johor Cancer Foundation (TLJCF) received a RM15,000 contribution from Daiman Group. “We would like to help cancer patients who cannot afford the often expensive treatment costs,” said the group’s managing director Tay Thiam Song after presenting a